(HealthDay)—For patients with heart failure due to light-chain amyloidosis (AL), three-drug therapy with bortezomib, dexamethasone, and an alkylating agent (BDex+AA) is associated with improved survival, according to a ...
Jun 21, 2016
0
34
In a guideline update published today, the American College of Cardiology, the American Heart Association and the Heart Failure Society of America detail the groups' recommendations for the use of two new heart failure medications.
May 23, 2016
0
0
European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chronic heart failure are published today in European Heart Journal and the European Journal of Heart Failure, and presented at ...
May 20, 2016
0
21
Chronic heart failure (CHF) patients with predominant central sleep apnea (CSA) are at higher risk for death and unplanned hospitalization than those who have both CSA and obstructive sleep apnea (OSA), whether or not they ...
May 18, 2016
0
8
Patients with a combination of left ventricular dysfunction and low aortic valve gradient, or reduced force of blood flow through the aortic valve, have higher mortality rates and a greater risk of recurrent heart failure ...
May 16, 2016
0
1
When electrical waves in the heart run amok in a condition called arrhythmia, sudden death can occur. To save the life of a patient at risk, doctors currently implant a small defibrillator to sense the onset of arrhythmia ...
May 10, 2016
0
68
(HealthDay)—Glaucoma may be associated with lower fractional anisotropy in the optic radiations, forceps major, and corpus callosum, possibly as a result of white matter degeneration, according to a study published online ...
May 2, 2016
0
12
A daily dose of vitamin D3 improves heart function in people with chronic heart failure, a five-year University of Leeds research project has found.
Apr 4, 2016
0
632
Cardiac stem cells could be an effective treatment for a common but difficult-to-treat type of heart failure, a new study from the Cedars-Sinai Heart Institute shows.
Feb 29, 2016
0
34
(HealthDay)—Only one-in-five patients with heart failure with reduced ejection fraction (HFrEF) receive digoxin at discharge, according to a study published online Feb. 10 in JACC: Heart Failure.
Feb 12, 2016
0
1
